Journal
ONCOTARGET
Volume 7, Issue 30, Pages 46899-46912Publisher
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.10380
Keywords
humanin; ERK1/2; AKT; STAT3; signaling pathway; Gerotarget
Categories
Funding
- Ellison/AFAR Postdoctoral Fellowship in Aging Research Program
- NIH [1R01GM090311, 1R01ES020812]
Ask authors/readers for more resources
Humanin is a small secreted peptide that is encoded in the mitochondrial genome. Humanin and its analogues have a protective role in multiple age-related diseases including type 2 diabetes and Alzheimer's disease, through cytoprotective and neuroprotective effects both in vitro and in vivo. However, the humanin-mediated signaling pathways are not well understood. In this paper, we demonstrate that humanin acts through the GP130/IL6ST receptor complex to activate AKT, ERK1/2, and STAT3 signaling pathways. Humanin treatment increases phosphorylation in AKT, ERK 1/2, and STAT3 where PI3K, MEK, and JAK are involved in the activation of those three signaling pathways, respectively. Furthermore, old mice, but not young mice, injected with humanin showed an increase in phosphorylation in AKT and ERK1/2 in the hippocampus. These findings uncover a key signaling pathway of humanin that is important for humanin's function and also demonstrates an age-specific in vivo effect in a region of the brain that is critical for memory formation in an age-dependent manner.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available